Literature DB >> 20798475

Serum FSH level below 10 mIU/mL at twelve years old is an index of spontaneous and cyclical menstruation in Turner syndrome.

Keiko Aso1, Shinobu Koto, Asako Higuchi, Daisuke Ariyasu, Masako Izawa, Junko Miyamoto Igaki, Yukihiro Hasegawa.   

Abstract

The gonadal function of patients with Turner syndrome (TS) is variable. Individuals with mosaicism characterized by 45,X/46,XX or 45,X/47,XXX are more likely to experience spontaneous menarche compared with other karyotypes. Prepubertal gonadotropins of TS patients with spontaneous menarche are reportedly normal or significantly lower than those of patients with induced menarche. The present study investigated an index of spontaneous and cyclical menstruation at 10-12 years old in TS. Subjects comprised 50 patients with TS, divided into three groups: Group A (n=7), with spontaneous menarche before 16 years old and regular menstruation for at least 1 year and 6 months; Group B (n=6), with irregular menstruation since menarche leading to secondary amenorrhea despite spontaneous menarche before 16 years old; and Group C (n=37), without spontaneous breast budding before 14 years old or without spontaneous menarche before 16 years old. Karyotype, LH and FSH concentrations at 10 and 12 years old were analyzed retrospectively. Spontaneous and cyclical menstruation was more frequently observed in TS with mosaicism characterized by 45,X/46,XX or 45,X/47,XXX than in TS with other karyotypes, as previously described. Spontaneous and cyclical menstruation in TS was observed when serum FSH level was <10 mIU/mL at 12 years old, suggesting this FSH level as an index of spontaneous and cyclical menstruation in TS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20798475     DOI: 10.1507/endocrj.k10e-092

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  6 in total

1.  Effects of low-dose estrogen replacement during childhood on pubertal development and gonadotropin concentrations in patients with Turner syndrome: results of a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Charmian A Quigley; Xiaohai Wan; Sipi Garg; Karen Kowal; Gordon B Cutler; Judith L Ross
Journal:  J Clin Endocrinol Metab       Date:  2014-04-24       Impact factor: 5.958

2.  Ovarian function in Duarte galactosemia.

Authors:  Jennifer R Badik; Uriel Castañeda; Tyler J Gleason; Jessica B Spencer; Michael P Epstein; Can Ficicioglu; Kristi Fitzgerald; Judith L Fridovich-Keil
Journal:  Fertil Steril       Date:  2011-06-29       Impact factor: 7.329

3.  Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline.

Authors:  A Nordenström; S F Ahmed; E van den Akker; J Blair; M Bonomi; C Brachet; L H A Broersen; H L Claahsen-van der Grinten; A B Dessens; A Gawlik; C H Gravholt; A Juul; C Krausz; T Raivio; A Smyth; P Touraine; D Vitali; O M Dekkers
Journal:  Eur J Endocrinol       Date:  2022-04-21       Impact factor: 6.558

Review 4.  Reproductive Issues in Women with Turner Syndrome.

Authors:  Lisal J Folsom; John S Fuqua
Journal:  Endocrinol Metab Clin North Am       Date:  2015-09-03       Impact factor: 4.741

Review 5.  Ultra-low-dose estrogen therapy for female hypogonadism.

Authors:  Yukihiro Hasegawa; Tomoyo Itonaga; Kento Ikegawa; Satsuki Nishigaki; Masanobu Kawai; Eri Koga; Hideya Sakakibara; Judith L Ross
Journal:  Clin Pediatr Endocrinol       Date:  2020-04-16

6.  Gene dosage as a relevant mechanism contributing to the determination of ovarian function in Turner syndrome.

Authors:  Chiara Castronovo; Raffaella Rossetti; Daniela Rusconi; Maria P Recalcati; Chiara Cacciatore; Elena Beccaria; Valeria Calcaterra; Pietro Invernizzi; Daniela Larizza; Palma Finelli; Luca Persani
Journal:  Hum Reprod       Date:  2013-12-08       Impact factor: 6.918

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.